Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.
Lee H, Koo BK, Park KW, Shin ES, Lim SW, Rha SW, Bae JW, Jeon DW, Oh SK, Hur SH, Kim BS, Lee JH, Park TH, Lee NH, Kim HS; HOST-EXAM investigators. Lee H, et al. Among authors: shin es. Am Heart J. 2017 Mar;185:17-25. doi: 10.1016/j.ahj.2016.12.001. Epub 2016 Dec 9. Am Heart J. 2017. PMID: 28267471
Multi-modality imaging for stent edge assessment.
Ann SH, Lim KH, De Jin C, Shin ES. Ann SH, et al. Among authors: shin es. Heart Vessels. 2015 Mar;30(2):162-8. doi: 10.1007/s00380-014-0467-x. Epub 2014 Jan 31. Heart Vessels. 2015. PMID: 24481539
A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
Park KW, Kang SH, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Hur SH, Ryu JK, Lee BR, Park YW, Chae IH, Kim HS; HOST–ASSURE Investigators. Park KW, et al. Among authors: shin es. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2805-16. doi: 10.1016/j.jacc.2014.04.013. Epub 2014 May 7. J Am Coll Cardiol. 2014. PMID: 24814486 Free article. Clinical Trial.
Assessment of stent edge dissections by fractional flow reserve.
Chung JH, Ann SH, Koo BK, Nam CW, Doh JH, Singh GB, Kim HI, Shin ES. Chung JH, et al. Among authors: shin es. Int J Cardiol. 2015 Apr 15;185:29-33. doi: 10.1016/j.ijcard.2015.03.043. Epub 2015 Mar 4. Int J Cardiol. 2015. PMID: 25777285
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.
Lee JM, Jung JH, Park KW, Shin ES, Oh SK, Bae JW, Rhew JY, Lee N, Kim DB, Kim U, Han JK, Lee SE, Yang HM, Kang HJ, Koo BK, Kim S, Cho YK, Shin WY, Lim YH, Rha SW, Kim SY, Lee SY, Kim YD, Chae IH, Cha KS, Kim HS. Lee JM, et al. Among authors: shin wy, shin es. Trials. 2015 Sep 15;16:409. doi: 10.1186/s13063-015-0925-5. Trials. 2015. PMID: 26374625 Free PMC article. Clinical Trial.
506 results